Page last updated: 2024-08-16

temozolomide and rg2833

temozolomide has been researched along with rg2833 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, BD; Chen, L; Li, QZ; Li, WP; Li, ZY; Wang, B; Zhang, XJ	1

Other Studies

1 other study(ies) available for temozolomide and rg2833

Article	Year
Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines. Neurochemical research, 2016, Volume: 41, Issue:12 Topics: Acetylation; Active Transport, Cell Nucleus; Antineoplastic Agents, Alkylating; Apoptosis; Benzamides; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Central Nervous System Neoplasms; Dacarbazine; Drug Resistance, Neoplasm; Drug Synergism; Glioblastoma; Histone Deacetylase Inhibitors; Homeodomain Proteins; Humans; NF-kappa B; Signal Transduction; Temozolomide; Transcription Factor RelA; Transcription, Genetic; Transcriptional Activation; Tumor Suppressor Proteins	2016

Article

Year

Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.

Neurochemical research, 2016, Volume: 41, Issue:12

Topics: Acetylation; Active Transport, Cell Nucleus; Antineoplastic Agents, Alkylating; Apoptosis; Benzamides; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Central Nervous System Neoplasms; Dacarbazine; Drug Resistance, Neoplasm; Drug Synergism; Glioblastoma; Histone Deacetylase Inhibitors; Homeodomain Proteins; Humans; NF-kappa B; Signal Transduction; Temozolomide; Transcription Factor RelA; Transcription, Genetic; Transcriptional Activation; Tumor Suppressor Proteins

2016